Clinical Trials
2 trialsNCT05111444 2021-11-08
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Fudan University
Phase 2 Unknown
NCT02500199 2021-02-01
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
Hengrui Therapeutics, Inc.
Phase 1 Unknown